Literature DB >> 30047423

Monosomy 7 in Pediatric Myelodysplastic Syndromes.

Marcin W Wlodarski1, Sushree S Sahoo2, Charlotte M Niemeyer3.   

Abstract

Myelodysplastic syndromes (MDS) in children and adolescents are a rare heterogeneous group of clonal stem cell disorders. Complete or partial loss of chromosome 7 constitutes the most common cytogenetic abnormality encountered in any type of childhood MDS, is associated with more advanced disease, and usually requires a timely allogeneic stem cell transplantation. This article provides insights into the current understanding of the genotype, phenotype, and clonal evolution patterns in pediatric MDS associated with loss of chromosome 7.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GATA2; Monosomy 7; Pediatric MDS; SAMD9; SAMD9L

Mesh:

Year:  2018        PMID: 30047423     DOI: 10.1016/j.hoc.2018.04.007

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  7 in total

Review 1.  Genetic predisposition to MDS: clinical features and clonal evolution.

Authors:  Alyssa L Kennedy; Akiko Shimamura
Journal:  Blood       Date:  2019-01-22       Impact factor: 22.113

2.  Therapeutic discovery for marrow failure with MDS predisposition using pluripotent stem cells.

Authors:  Melisa Ruiz-Gutierrez; Özge Vargel Bölükbaşı; Gabriela Alexe; Adriana G Kotini; Kaitlyn Ballotti; Cailin E Joyce; David W Russell; Kimberly Stegmaier; Kasiani Myers; Carl D Novina; Eirini P Papapetrou; Akiko Shimamura
Journal:  JCI Insight       Date:  2019-04-30

3.  Genetic predisposition to MDS: diagnosis and management.

Authors:  Elissa Furutani; Akiko Shimamura
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

4.  Case Report: Refractory Cytopenia With a Switch From a Transient Monosomy 7 to a Disease-Ameliorating del(20q) in a NHEJ1-Deficient Long-term Survivor.

Authors:  Fiona Poyer; Raúl Jimenez Heredia; Wolfgang Novak; Petra Zeitlhofer; Karin Nebral; Michael N Dworzak; Oskar A Haas; Kaan Boztug; Leo Kager
Journal:  Front Immunol       Date:  2022-06-24       Impact factor: 8.786

Review 5.  Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies.

Authors:  Serine Avagyan; Akiko Shimamura
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

Review 6.  Human GATA2 mutations and hematologic disease: how many paths to pathogenesis?

Authors:  Emery H Bresnick; Mabel M Jung; Koichi R Katsumura
Journal:  Blood Adv       Date:  2020-09-22

7.  Aberrant Expression of EZH2 in Pediatric Patients with Myelodysplastic Syndrome: A Potential Biomarker of Leukemic Evolution.

Authors:  Teresa de Souza Fernandez; Tatiana Fonseca Alvarenga; Elaiza Almeida Antônio de Kós; Viviane Lamim Lovatel; Rita de Cássia Tavares; Elaine Sobral da Costa; Cecília de Souza Fernandez; Eliana Abdelhay
Journal:  Biomed Res Int       Date:  2019-12-10       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.